CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Coronavirus Disease 2019Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug2288 Spinal Anesthesia Position Wiki 1.00

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Detection Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Male Genitourinary System and Its Impact on Male Reproductive Health: an Observational Clinical Study.

This study will evaluate the changes in sexual function, reproductive function and mental health of male patients discharged from the hospital with COVID-19, and the impact of SARS-CoV-2 on male reproductive health and mental health compared with healthy people during the same period. In addition, men's semen examination reports before and after the new coronavirus pneumonia event will be collected and compared to assess the impact of the event on the quality of men's semen. Also, This study will test the SARS-CoV-2 nucleic acid of the urogenital system of male patients discharged with COVID-19 to provide evidence for the effect of the new coronavirus on the male reproductive system.

NCT04388631 Coronavirus Disease 2019 Other: Coronavirus Disease 2019
MeSH:Coronavirus Infections

Primary Outcomes

Description: Sperm density will be obtained in the semen sample analysis using the World Health Organization (WHO) normal values based on the WHO 2010 reference limits.

Measure: Sperm density

Time: 3 months

Description: Sperm activity will be obtained in the semen sample analysis using the World Health Organization (WHO) normal values based on the WHO 2010 reference limits.

Measure: Sperm activity

Time: 3 months

Description: Erection hardness and duration will be evaluated during sleep by RigiscanHealth Organization (WHO) normal values based on the WHO 2010 reference limits.

Measure: Erection hardness and duration

Time: 3 months

Description: IIEF-5/QEQ questionnaire score will be obtained by filling out the questionnaire every visit.

Measure: IIEF-5/QEQ questionnaire score

Time: 3 months

Description: Detection rate of SARS-CoV-2 in male genitourinary system will be evaluated by real time-polymerase chain reaction (RT-PCR).

Measure: Detection rate of SARS-CoV-2 in male genitourinary system

Time: 1 month

Secondary Outcomes

Description: Sperm volume will be obtained in the semen sample analysis using the World Health Organization (WHO) normal values based on the WHO 2010 reference limits.

Measure: Semen volume

Time: 3 months

Description: Sperm survival rate will be obtained in the semen sample analysis using the World Health Organization (WHO) normal values based on the WHO 2010 reference limits.

Measure: Sperm survival rate

Time: 3 months

Description: The serum testosterone/LH/FSH levels will be tested in every visit.

Measure: Serum testosterone/luteinizing hormone (LH)/follicle stimulating hormone (FSH) level

Time: 3 months

Description: SCL-90 questionnaire score will be obtained using SCL-90 questionnaire.

Measure: SCL-90 questionnaire score

Time: 3 months

Other Outcomes

Description: Height will be measured at every visit

Measure: Height

Time: 3 months

Description: Weight will be measured at every visit

Measure: Weight

Time: 3 months

Description: Clinical classification of COVID-19 will be determined according to the New Coronavirus Pneumonia Prevention and Control Program (7th edition) published by the National Health Commission of China

Measure: Clinical classification of COVID-19

Time: 1 month

No related HPO nodes (Using clinical trials)